|
시장보고서
상품코드
2055359
인공폐 시장 : 제품 유형별, 환자 유형별, 최종 사용자별, 지역별Artificial Lung Market, By Product Type, By Patient Type, By End User, By Geography |
||||||
인공폐 시장은 2026년에 23억 2,000만 달러에 달하고 2033년까지 46억 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 10.3%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 23억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.30% | 시장 규모 예측(2033년) : | 46억 달러 |
세계 인공폐 시장은 의료기기 산업 전반에서 중요한 부분을 차지하고 있으며, 중증 호흡기 질환 환자의 자연스러운 폐 기능을 일시적 또는 영구적으로 대체하도록 설계된 첨단 생명 유지 기술에 중점을 두고 있습니다.
인공폐는 체외막산소화(ECMO) 시스템 또는 기계적 폐보조장치라고도 불리며, 급성호흡곤란증후군(ARDS), 만성폐쇄성폐질환(COPD), 폐색전증 및 기타 생명을 위협하는 호흡부전에 시달리는 환자들에게 필수적인 치료 솔루션으로 기능합니다. 이러한 첨단 생체의료기기는 체외에서 혈액에 산소를 공급하고 이산화탄소를 제거함으로써 작동하며, 본래 건강한 폐가 담당하는 가스 교환 기능을 효과적으로 대신합니다.
이 시장에는 막형 산소화 장치, 인공폐 임플란트, 웨어러블 인공폐 시스템 등 다양한 기술적 접근 방식이 포함되어 있으며, 각각은 특정 환자의 요구 사항이나 임상 상황에 부응하도록 설계되었습니다. 전 세계 호흡기 질환 유병률 증가, 고령화, 그리고 최근 호흡기계 팬데믹의 영향으로 인해, 인공폐 시장은 중환자 치료 환경에서 생명을 구하는 의료 과제를 해결하고 환자의 예후를 개선하기 위한 혁신적인 솔루션을 모색하는 의료진, 의료기기 제조업체, 투자자들로부터 큰 주목을 받고 있습니다.
시장 역학
세계 인공폐 시장은 주로 만성 폐쇄성 폐질환, 급성 호흡곤란 증후군, 폐섬유증 등 전 세계적으로 증가하는 호흡기 질환의 유병률에 힘입어 성장하고 있습니다. 이러한 질환들은 전 세계 수백만 명의 환자에게 영향을 미치고 있으며, 첨단 호흡 보조 기술에 대한 막대한 수요를 창출하고 있습니다. 전 세계적인 고령화 현상 또한 시장 성장에 크게 기여하고 있습니다. 고령자는 호흡기 합병증에 걸리기 쉽고 집중 치료가 필요한 경향이 있는 반면, 생체 적합성 소재, 소형화, 가스 교환 효율 향상과 같은 기술적 진보로 인해 인공폐 시스템의 성능과 안전성이 향상되고 있습니다.
코로나19 팬데믹은 호흡 보조 기기의 필요성을 부각시키고 전 세계 의료 인프라에 대한 투자를 늘림으로써 시장 확대를 특히 가속화했습니다. 그러나 시장 성장에는 인공폐 장치 및 그 유지 관리에 따르는 막대한 비용, 제품 출시를 지연시킬 수 있는 복잡한 규제 승인 절차, 그리고 이러한 침습적 시술에 수반되는 출혈, 감염, 혈전증 등의 심각한 합병증 위험 등 상당한 제약이 따릅니다. 고급 인공폐 시스템 조작에 능숙한 의료진의 부족에 더해, 개발도상 지역에서 이러한 장비를 구하기 어렵다는 점이 시장 보급을 더욱 제한하고 있습니다. 그럼에도 불구하고, 생명공학 분야, 특히 환자 치료에 혁명을 일으킬 수 있는 이식형 인공폐나 웨어러블 기기의 개발을 위한 지속적인 연구 개발을 통해 큰 기회가 존재합니다.
예측 모니터링 및 자동 조정을 위한 인공지능(AI)과 머신러닝 기술의 통합은 시장 확대를 위한 유망한 방향을 제시하고 있습니다. 한편, 신흥 시장의 의료비 증가와 첨단 호흡기 치료 솔루션에 대한 인식 제고 또한 새로운 성장 기회를 창출하고 있습니다. 의료기기 제조업체와 의료기관 간의 전략적 제휴, 그리고 응급의료 인프라 구축을 지원하는 정부의 이니셔티브이 인공폐 분야의 지속적인 시장 성장과 혁신을 이끌 것으로 예측됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 세계 인공폐 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 인공폐 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계의 인공폐 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 인공폐 시장 : 제품 유형별(2021-2033년)
제5장 세계의 인공폐 시장 : 기술별(2021-2033년)
제6장 세계의 인공폐 시장 : 휴대성별(2021-2033년)
제7장 세계의 인공폐 시장 : 용도별(2021-2033년)
제8장 세계의 인공폐 시장 : 환자 유형별(2021-2033년)
제9장 세계의 인공폐 시장 : 최종 사용자별(2021-2033년)
제10장 세계의 인공폐 시장 : 지역별(2021-2033년)
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
KTH 26.06.19Artificial Lung Market is estimated to be valued at USD 2.32 Bn in 2026 and is expected to reach USD 4.60 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.32 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.30% | 2033 Value Projection: | USD 4.60 Bn |
The global artificial lung market represents a critical segment within the broader medical device industry, focusing on advanced life-support technologies designed to temporarily or permanently replace natural lung function in patients with severe respiratory conditions.
Artificial lungs, also known as extracorporeal membrane oxygenation (ECMO) systems or mechanical lung support devices, serve as vital therapeutic solutions for patients suffering from acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), pulmonary embolism, and other life-threatening respiratory failures. These sophisticated biomedical devices function by oxygenating blood and removing carbon dioxide outside the body, effectively performing the gas exchange function typically handled by healthy lungs.
The market encompasses various technological approaches, including membrane oxygenators, artificial lung implants, and wearable artificial lung systems, each designed to address specific patient needs and clinical scenarios. With the increasing prevalence of respiratory diseases globally, aging populations, and the recent impact of respiratory pandemics, the artificial lung market has gained significant attention from healthcare providers, medical device manufacturers, and investors seeking innovative solutions to address critical care challenges and improve patient outcomes in intensive care settings.
Market Dynamics
The global artificial lung market is primarily driven by the escalating prevalence of respiratory diseases worldwide, including chronic obstructive pulmonary disease, acute respiratory distress syndrome, and pulmonary fibrosis, which collectively affect millions of patients globally and create substantial demand for advanced respiratory support technologies. The aging global population significantly contributes to market growth, as elderly individuals are more susceptible to respiratory complications and require intensive care interventions, while technological advancements in biocompatible materials, miniaturization, and improved gas exchange efficiency have enhanced the performance and safety profiles of artificial lung systems.
The COVID-19 pandemic has particularly accelerated market expansion by highlighting the critical need for respiratory support devices and increasing healthcare infrastructure investments globally. However, market growth faces considerable restraints, including the extremely high costs associated with artificial lung devices and their maintenance, complex regulatory approval processes that can delay product launches, and the significant risk of complications such as bleeding, infection, and thrombosis associated with these invasive procedures. The shortage of skilled healthcare professionals trained in operating sophisticated artificial lung systems, coupled with limited availability of these devices in developing regions, further constrains market penetration. Nevertheless, substantial opportunities exist through ongoing research and development in bioengineering, particularly in developing implantable artificial lungs and wearable devices that could revolutionize patient care.
The integration of artificial intelligence and machine learning technologies for predictive monitoring and automated adjustments presents promising avenues for market expansion, while increasing healthcare expenditure in emerging markets and growing awareness about advanced respiratory care solutions create new growth opportunities. Strategic partnerships between medical device manufacturers and healthcare institutions, along with government initiatives supporting critical care infrastructure development, are expected to drive sustained market growth and innovation in the artificial lung sector.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global artificial lung market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, ALung Technologies, Inc., Breethe, Inc., Miromatrix Medical Inc., Abiomed, Inc., Cyanagen Srl, Nipro Corporation, and Hemovent GmbH
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global artificial lung market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial lung market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Extracorporeal Membrane Oxygenation (ECMO) Systems
- Veno-Arterial (VA) ECMO
- Veno-Venous (VV) ECMO
- Paracorporeal Artificial Lungs
- Pumpless Paracorporeal Devices
- Pump-Assisted Paracorporeal Devices
- Implantable Artificial Lungs
- Intrathoracic Devices
- Vascular Graft-Integrated Devices
- Others (Oxygenators)
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Perfusion Systems
- Membrane Oxygenation Technology
- Microfluidic Oxygenators
- Biohybrid Systems
- Pumpless Gas Exchange Systems
- Others (3D-Printed Artificial Lung Constructs, etc.)
- Portability Insights (Revenue, USD Bn, 2021 - 2033)
- Stationary Systems
- Portable Systems
- Wearable Systems
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Lung Transplant Support (Bridge-to-Transplant)
- Acute Respiratory Distress Syndrome (ARDS)
- Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
- Others (Coronary Artery Bypass Grafting, etc.)
- Patient Type Insights (Revenue, USD Bn, 2021 - 2033)
- Neonates
- Pediatric
- Adult
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Transplant Centers
- Ambulatory Surgical Centers
- Emergency and Trauma Centers
- Home Care Settings (for wearable devices)
- Others (Research Institutes, etc.)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic plc
- Getinge AB
- LivaNova PLC
- Terumo Corporation
- Fresenius Medical Care AG & Co. KGaA
- ALung Technologies, Inc.
- Breethe, Inc.
- Miromatrix Medical Inc.
- Abiomed, Inc.
- Cyanagen Srl
- Nipro Corporation
- Hemovent GmbH
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Artificial Lung Market, By Product Type
- Global Artificial Lung Market, By Technology
- Global Artificial Lung Market, By Portability
- Global Artificial Lung Market, By Application
- Global Artificial Lung Market, By Patient Type
- Global Artificial Lung Market, By End User
- Global Artificial Lung Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Artificial Lung Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Extracorporeal Membrane Oxygenation (ECMO) Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Veno-Arterial (VA) ECMO
- Veno-Venous (VV) ECMO
- Paracorporeal Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pumpless Paracorporeal Devices
- Pump-Assisted Paracorporeal Devices
- Implantable Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intrathoracic Devices
- Vascular Graft-Integrated Devices
- Others (Oxygenators)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Artificial Lung Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Perfusion Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Membrane Oxygenation Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microfluidic Oxygenators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biohybrid Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pumpless Gas Exchange Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (3D-Printed Artificial Lung Constructs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Artificial Lung Market, By Portability, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Stationary Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Portable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Wearable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Artificial Lung Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Lung Transplant Support (Bridge-to-Transplant)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Acute Respiratory Distress Syndrome (ARDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Coronary Artery Bypass Grafting, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Artificial Lung Market, By Patient Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Artificial Lung Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Emergency and Trauma Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings (for wearable devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Artificial Lung Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Medical Care AG & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ALung Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Breethe, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miromatrix Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abiomed, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cyanagen Srl
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nipro Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hemovent GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
